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Abstract
The Myc oncoprotein is a transcription factor involved in a variety of human cancers. Overexpression of Myc is associated
with malignant transformation. In normal cells, Myc is induced by mitotic signals, and in turn, it regulates the expression of
downstream target genes. Although diverse roles of Myc have been predicted from many previous studies, detailed
functions of Myc targets are still unclear. By combining chromatin immunoprecipitation (ChIP) and promoter microarrays,
we identified a total of 1469 Myc direct target genes, the majority of which are novel, in HeLa cells and human primary
fibroblasts. We observed dramatic changes of Myc occupancy at its target promoters in foreskin fibroblasts in response to
serum stimulation. Among the targets of Myc, 107 were nuclear encoded genes involved in mitochondrial biogenesis.
Genes with important roles in mitochondrial replication and biogenesis, such as POLG, POLG2, and NRF1 were identified as
direct targets of Myc, confirming a direct role for Myc in regulating mitochondrial biogenesis. Analysis of target promoter
sequences revealed a strong preference for Myc occupancy at promoters containing one of several described consensus
sequences, CACGTG, in vivo. This study thus sheds light on the transcriptional regulatory networks mediated by Myc in vivo.
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Introduction
The Myc oncogene is a transcription factor that has important
roles in regulation of the cell cycle, proliferation, differentiation,
apoptosis, and miRNA activation [1,2,3,4]. Deregulation of Myc
expression by translocation causes Burkitt’s lymphoma [5,6].
Several studies have shown that Myc expression is increased in
many different tumors, indicating that a high level of Myc favors
uncontrolled cell proliferation, inhibits cell differentiation and
contributes to tumorigenesis [7].
Several Myc-related genes, such as c-Myc, N-Myc, L-Myc, and
S-Myc are known in mammals [8], and among them, c-Myc, N-
Myc, and L-Myc have been implicated in the genesis of human
tumors [9]. A basic helix-loop-helix leucine zipper (bHLH/LZ)
protein, Myc dimerizes with another bHLH/LZ protein, Max, to
function as a sequence specific DNA-binding transcription factor
[10,11]. Max forms Max-Max homodimers or heterodimerizes
with Mad family proteins [9]. Myc-Max heterodimers are believed
to generally function as an activator complex and Mad-Max
heterodimers function as a repressor complex [12,13]. However,
some studies have shown that Max also mediates Myc-dependent
transcriptional repression [14], and that Myc represses the
transcription of downstream target genes by interfering with the
function of other transcriptional activators such as Miz-1 [15], NF-
Y [16], or Sp1 [17]. Given the functions of Myc in various
biological processes, identifying the downstream targets of Myc
has been an area of active research. Genome-wide analysis using
microarrays and serial analysis of gene expression (SAGE) suggest
that Myc could regulate several hundred genes in mammalian cells
[18,19]. More than a thousand targets of Myc in mammalian cells
have been identified and compiled in public databases, which
however include direct as well as secondary targets [20].
More recently, genome-wide chromatin immunoprecipitation
studies [14,21,22] have been performed in different cellular
contexts to identify approximately 1300 direct binding target sites
of Myc. These studies suggest that about 15% of all annotated
genes are direct targets of Myc. Although some of these studies
were comprehensive, the overlap between Myc targets identified in
different large scale studies is small. It is thus likely that our
knowledge of the targets and therefore, the functions, of this
oncogene is still limited, given the possibility that it regulates
distinct sets of targets in different cell types and physiological
growth conditions. Changes in the binding of Myc to its target sites
in different physiological conditions in the same cell type have not
been systematically examined. Although many previous studies
have implicated Myc regulation of many cellular processes, in
general, it is not clear whether regulation by Myc occurs by virtue
of its position at the head of a transcriptional regulatory cascade,
or whether these processes are regulated directly by Myc binding
to the promoters of the relevant targets. Myc is known to bind to a
canonical consensus DNA sequence CACGTG, termed the E-box,
but has also been reported to bind in vitro to several other non-
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CACGCG, CACGAG, and CAACGTG [23]. However, it is
not clear whether Myc exhibits significant selectivity with regard to
these sequence motifs in binding to its target sites in the genome.
Here, we identified 1469 Myc direct binding target genes in
HeLa cells and human foreskin fibroblasts using human core
promoter microarrays. A majority of these targets have not been
identified as Myc targets before and hence are novel. We observed
a dramatic increase in Myc binding to its target promoters in
response to serum stimulation in normal fibroblasts. A strikingly
significant fraction of Myc direct target genes were those involved
in mitochondrial biogenesis. Additionally, we also analyzed the
usage of Myc consensus sequences in vivo and show that the
canonical E-box CACGTG and non-canonical CACGCG
sequences are the major motifs that are utilized by Myc in
binding its target promoters in vivo.
Results and Discussion
Myc binds to many target gene promoters in HeLa cells
We used human promoter microarrays that contained 9,303
proximal promoters to identify the direct targets of Myc in two
different human cell lines, HeLa cells and primary foreskin
fibroblasts. The genomic regions between –750 bp and +250 bp
relative to transcriptional start sites (TSS) of well annotated genes
were amplified and printed on the microarrays [24]. We carried
out independent ChIP reactions from four independently grown
HeLa cell cultures and co-hybridized the ChIP samples together
with a mock immunoprecipitated sample as the reference. We
determined the median ratio of each spot on the microarray from
the four independent hybridizations, and also calculated a p-value
for significant ratios using a previously described error model
[25,26]. We considered spots with a ratio $2.0 and P value
#0.005 to represent direct Myc target loci. Among the 9,303
promoter spots analyzed, 1351 spots were in this category
(Figure 1A). Control hybridizations with differentially labeled
mock immunoprecipitated samples did not yield any significantly
enriched loci at this threshold (data not shown).
Occupancy of target promoters by Myc changes rapidly
in response to serum activation of quiescent fibroblasts
The response to serum stimulation has been used as a model for
studying mammalian cell cycle activation and proliferation
[27,28]. These studies have led to the identification of Myc as a
critical downstream element of proliferation signaling cascades. As
an immediate early response transcription factor, the expression
levels of Myc mRNA and protein are rapidly induced by a variety
of growth factors and serum stimulation [29,30]. Based on the fact
that expression of Myc is strongly and rapidly induced by serum
stimulation, and the fact that Myc is known to be an important
regulator of cell proliferation, we hypothesized that Myc might
show changes in binding to its target promoters in response to
serum stimulation. To determine if this was the case, we measured
the occupancy of Myc at target promoters in quiescent foreskin
fibroblasts as well as in fibroblasts after serum stimulation. Two
independent cultures of quiescent foreskin fibroblasts grown in low
serum (0.1% FBS) media for 72 hours, as well as fibroblasts
stimulated by serum (10% FBS) for 4 hours were used for ChIP,
and hybridizations were carried out as described for HeLa cells
above, using a mock immunoprecipitated sample as reference. We
averaged the ratios from duplicate microarray hybridizations and
used the same threshold as for HeLa cells to define the target
promoters occupied by Myc in foreskin fibroblasts. We detected
196 promoters occupied by Myc in quiescent fibroblasts
(Figure 1B), whereas 788 promoters were occupied by Myc in
response to serum stimulation (Figure 1C). Our result thus reveals
differential binding of Myc to its target promoters under different
growth conditions in the same cell type. Interestingly, Myc
occupied a much larger number of target promoters in HeLa cells
although the HeLa cells used in our study were not synchronized.
Altogether, we identified 1469 direct downstream targets of Myc
from at least one of the conditions we tested.
We compared the Myc targets identified in HeLa cells with the
Myc targets in fibroblasts to see if there were any differences in
target profiles among cell lines or different growth conditions.
There were many common Myc targets among the different
conditions we examined. Approximately 86% (676 out of 788)
of the Myc targets in serum-stimulated fibroblasts were also
targets in HeLa cells (Figure 1D). 86% (169 out of 196) of Myc
targets in quiescent fibroblasts were also targets of Myc in serum
stimulated fibroblasts, and 95% (185 out of 196) of them were also
Myc targets in HeLa cells (Figure 1D). Interestingly, a more
continuous analysis of target overlaps based on pair-wise global
comparisons of each data set (Figure 2A–C) suggested that the
occupancy of target promoters by Myc was largely consistent
across cell lines and growth conditions. Thus, the differences
between its binding targets in HeLa cells and fibroblasts are likely
to reflect lower levels of Myc in fibroblasts, rather than its
occupancy of a markedly different set of targets in the different
cells or conditions.
Since Myc expression is induced by serum stimulation, the small
set of genes (27) whose promoters were occupied by Myc in serum
starved fibroblasts and not in serum stimulated fibroblasts is
noteworthy. We examined expression changes of this subset of
genes upon serum stimulation, using an expression data set
published from our lab [31]. We found that this subset of Myc
targets included genes that are activated and repressed by serum
stimulation, as well as genes that show no significant expression
change (Supplementary Figure S1). This behavior is consistent
with the previously reported role for Myc as a repressor
[14,15,16,17], as well as the finding that Myc binding can
occur without a corresponding change in mRNA expression
levels [22].
A comparison with Myc target genes identified in previously
published large-scale experiments [14,22,32,33] also confirmed
that there were many targets in common between our study and
previous studies, even though each of these studies used different
cell lines and different experimental platforms (see Supplementary
Table S1). These overlaps do not however reflect some kind of
broad ChIP-chip artifact. As a negative control for our pair-wise
comparisons, we used data from an E2F4 ChIP-chip experiment.
As expected, the Myc occupancy and E2F4 occupancy datasets
showed much weaker correlations than the different Myc datasets
(Figure 2D).
The 1469 target genes of Myc in HeLa cells and foreskin
fibroblasts we report here form one of the largest sets of direct Myc
targets identified in a single experiment. 1104 of our 1469 targets
were not identified in other recent large-scale experiments
[14,22,32,34] (also listed in Supplementary Table S1). This is
likely in part because many of these studies used different cell
types. For example, Li et al used a smaller promoter microarray to
identify direct Myc targets in Burkitt lymphoma cells [33].
However, even though the overlap between the two target sets
was modest (46%), it was statistically highly significant (p,10
250).
Based on our results, and extrapolating from the coverage of
promoters on this array, we estimate that the number of direct
target genes of Myc in human cells totals approximately 16% of all
human genes.
Genome-Wide Myc Targets
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The direct Myc target genes we identified fell into a variety of
functional categories that suggested a role for Myc in diverse
cellular processes. We used DAVID [35] and FatiGO [36] to
quantitate the enrichment of different functional groups of
genes among its targets and confirm the involvement of
Myc in many processes identified in previous large scale
experiments, such as DNA, RNA, and protein metabolism,
transport, apoptosis, cell cycle, signal transduction, and cellular
proliferation (Supplementary Table S2). KEGG pathway
analysis [35] revealed that the Myc direct target genes we
identified by ChIP-chip are additionally involved in many
previously known and unknown pathways (Table 1). Ribosomal
genes comprised one of the most prominent previously known
sets of genes that Myc regulates directly, but our analysis
identified that it also directly regulates genes involved in oxidative
phosphorylation, aminoacyl-tRNA biosynthesis, and glutamate
metabolism.
Figure 1. Direct binding targets of Myc in HeLa cells, quiescent foreskin fibroblasts, and serum stimulated foreskin fibroblasts.
Fibroblasts are designated ‘‘2091’’. Target binding loci of Myc were detected by ChIP-chip analysis in (A) HeLa cells, (B) quiescent (serum starved for
3 days) foreskin fibroblasts, and (C) serum stimulated foreskin fibroblasts (for 4 hours). Each scatter plot shows the red/green ratio (log2 transformed)
on the Y-axis, and the p-value in X-axis. Red data points indicate Myc target loci with red/green log2 ratio .1 (2-fold), and p,0.005. 1351, 196, and
788 promoters were occupied by Myc respectively in the three conditions. (D) The Venn diagram compares target genes in HeLa cells, quiescent
foreskin fibroblasts, and serum stimulated foreskin fibroblasts. A total of 1469 target promoters were identified as targets of Myc. Microarray data are
also available through NCBI’s Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) under GEO Series accession number GSE5197.
doi:10.1371/journal.pone.0001798.g001
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It is known that Myc activates nuclear-encoded mitochondrial
gene expression [18], and that many direct targets of Myc are
involved in mitochondrial function [14,32,33]. Myc directly
regulates TFAM, a transcription factor important for mitochon-
drial transcription and mitochondrial DNA replication [21], as
well as PGC-1b, a regulator of mitochondrial biogenesis [37].
However, the full extent of the relationship between the direct role
of Myc acting at its target promoters and mitochondrial function
has not been systematically addressed. In addition to these
previously reported Myc targets that are involved in mitochondrial
biogenesis, it is possible that additional targets in this process are
also directly regulated by Myc by its binding to their promoters,
indicative of a concerted and multi-pronged regulation of
mitochondrial biogenesis by Myc. Indeed, our data and analysis
revealed that many functions and pathways that Myc target genes
are involved in are closely related to general mitochondrial
functions, such as metabolism, apoptosis, oxidative phosphoryla-
tion, and glutamate metabolism. It has been suggested that the
proliferation and cell cycle progression caused by Myc is in part
Figure 2. Myc binds largely to the same target loci among different cell types or physiological conditions. Myc binding to promoters is
represented by spots in each scatter plot on a log2 transformed scale. Comparisons of Myc occupancy at promoters (A) between HeLa cells and
quiescent foreskin fibroblasts, (B) between serum stimulated and quiescent foreskin fibroblasts, and (C) between HeLa cells and in serum stimulated
foreskin fibroblasts, show a relatively high degree of similarity of Myc binding targets in different cell lines or conditions.(D) As a negative control, a
comparison between E2F4 binding to promoters in quiescent fibroblasts and Myc binding to promoters in the same condition was performed. There
is little correlation between Myc occupancy and E2F4 occupancy at the promoters (R
2=0.19).
doi:10.1371/journal.pone.0001798.g002
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phosphorylation [21,38,39], which are critical for cell prolifera-
tion. However, only a few genes in these pathways have been
identified as direct targets of Myc [39]. We found that Myc
occupies the promoters of genes such as POLG, POLG2, and
NRF1, which have important roles in mitochondrial biogenesis.
The promoter of TFBM1, a mitochondrial transcription specificity
factor, showed a positive red/green ratio on the promoter
microarray, indicative of occupancy by Myc, although it did not
meet the p-value threshold for defining targets (R/G .2,
p=0.0283). NRF1, one of the direct Myc targets we identified,
is known to regulate nuclear encoded mitochondrial genes
including cytochrome c [39,40]. Our result thus suggests possible
co-regulation of mitochondrial biogenesis by a feed-forward
network loop involving Myc and NRF1. It has been previously
shown that the apoptotic function of Myc is mediated by NRF1
target genes, and that the balance of mitochondrial genes
regulated by Myc and NRF1 is important in cell viability [39].
Our finding suggests that Myc could be an upstream regulator of
NRF1 and both of these transcription factors are thus important
regulators of mitochondrial biogenesis and diverse mitochondrial
functions.
In order to systematically quantitate the extent of the
involvement of Myc in mitochondrial biogenesis, we searched
MitoP2, an integrated database of mitochondrial proteins [41]
which lists 785 RefSeq annotated genes, of which promoters for
337 were represented on our promoter arrays. 107 of these 337
mitochondrial genes showed a red/green ratio greater than 2 and
are listed in Supplementary Table S3. The red/green ratios of the
set of all mitochondrial gene promoters tended to be higher than
the overall red/green ratio of all promoters on the array, reflecting
higher occupancy of the former set of promoters by Myc
(Figure 3A).
The relationship between Myc binding and target gene
expression is not a simple one [42]. However, ectopic expression
of Myc is known to transcriptionally activate many nuclear genes
involved in mitochondrial biogenesis [21]. To determine if this was
also the case for the binding targets we identified by ChIP-chip, we
examined the level of mitochondrial gene expression in microarray
data. In HeLa cells containing high levels of Myc, the expression
levels of mitochondrial genes tended to be higher than the
background (Figure 3B), which is similar to the pattern of Myc
occupancy of its the target promoters (Figure 3A). We indepen-
dently verified the occupancy by Myc of the promoters of many of
these mitochondrial function genes, as well as several other targets
identified by our core promoters using quantitative real-time PCR
(Figure 3C). A gene-by-gene comparison of Myc binding and
target gene expression levels also showed that most of the nuclear
mitochondrial genes whose promoters were occupied by Myc were
transcriptionally active (Figure 3D). Taken together, our data
strongly support the notion that Myc directly binds to the
promoters of many nuclear encoded mitochondrial genes and
positively regulates the transcription of these genes.
In vivo usage of E-box elements by Myc
Myc regulates its downstream target genes by binding to cis-
acting DNA motifs called E-boxes. The canonical E-box sequences
CACGTG and CATGTG [23] as well as non-canonical E-boxes,
such as CATGCG, CACGCG, CACGAG, and CAACGTG have
been identified as cis-acting elements bound by Myc [43].
Although several E-boxes and E-box derivatives have been
identified, the E-box sequence preference of Myc for binding to
its chromosomal sites in vivo remains largely unknown. To
elucidate the relationship between Myc binding and each of the E-
box derivatives occurring in proximal promoters in vivo, we
analyzed our ChIP-chip data set.
We first examined the distribution of the previously defined E-
box sequences in all human core promoters, considering the
regions from 3,000 bp upstream to 1,000 bp downstream of the
transcription start sites of 18,193 well-annotated human genes in
RefSeq. Three of the six E-box sequences we analyzed–
CACGTG, CATGCG and CACGCG–showed a relative enrich-
ment in the promoter region between 800 bp upstream and
200 bp downstream of transcription start site (TSS), whereas in
Table 1. Functional categories of Myc target genes as indicated by KEGG pathways.
KEGG_PATHWAY: Term Count % PValue
HSA04110: Cell Cycle 25 1.73% 9.67E-05
HSA03010: Ribosome 40 2.77% 1.18E-04
HSA00190: Oxidative Phosphorylation 27 1.87% 5.53E-04
HSA00251: Glutamate Metabolism 10 0.69% 1.28E-03
HSA03030: DNA Polymerase 9 0.62% 1.49E-03
HSA00230: Purine Metabolism 27 1.87% 4.02E-03
HSA00970: Aminoacyl-tRNA Synthetases 9 0.62% 8.07E-03
HSA03060: Protein Export 6 0.42% 9.85E-03
HSA00351: 1,1,1-Trichloro-2,2-Bis(4-Chlorophenyl)Ethane (DDT) Degradation 3 0.21% 2.50E-02
HSA00630: Glyoxylate And Dicarboxylate Metabolism 5 0.35% 2.80E-02
HSA00440: Aminophosphonate Metabolism 6 0.42% 4.17E-02
HSA00350: Tyrosine Metabolism 11 0.76% 5.19E-02
HSA00626: Nitrobenzene Degradation 5 0.35% 5.70E-02
HSA00240: Pyrimidine Metabolism 15 1.04% 6.92E-02
HSA00193: ATP Synthesis 9 0.62% 7.75E-02
HSA00400: Phenylalanine, Tyrosine And Tryptophan Biosynthesis 4 0.28% 7.76E-02
1440 of the 1469 Myc targets were analyzed using the ‘Functional Annotation Tool’ in DAVID (http://david.abcc.ncifcrf.gov/).
doi:10.1371/journal.pone.0001798.t001
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bars) and at the subset of promoters of genes involved in mitochondrial biogenesis (black bars) is shown. (B) The histogram shows expression profiles
of all genes in HeLa cells detected by cDNA microarray (gray bars) and expression of genes involved in mitochondrial biogenesis (black bars). (C) Myc
occupancy at the promoters of selected target genes were independently verified by quantitative real-time PCR. The promoter of the actin gene
(ACTB) served as a negative control. The graph shows fold enrichment over background, as an average of triplicate PCR reactions from two
independent biological replicates. 20 of 24 tested promoters showed significant enrichment compared to the negative control. (D) A gene-by-gene
visualization of the correlation between Myc occupancy at the promoters of genes in mitochondrial biogenesis and gene expression in HeLa cells.
doi:10.1371/journal.pone.0001798.g003
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the same region (Figure 4A). The sequences CACGAG and
CAACGTG did not show any significant bias within the 4 kb core
promoter region that we analyzed. When we considered only the
promoter region between 800 bp upstream and 200 bp down-
stream, about 55% of all promoters of the RefSeq genes contained
at least one of the six E-box elements (Figure 4B). However, each
E-box sequence was found in less than 20% of all human
promoters.
Approximately 64% of promoters that were occupied by Myc in
our ChIP-chip analysis contained at least one of the six E-box
sequences. Thus, 36% of the promoters occupied by Myc in vivo
lacked any known E-box sequence. We then tested the relationship
between the presence of each E-box sequence and Myc occupancy
Figure 4. Distribution of E-box elements in human promoters and in vivo usage of E-box sequences in HeLa cells. (A) Distribution
(number of occurrences per bin as a function of position relative to the transcription start site (+1, TSS)) of each E-box sequence is shown. Of the six
previously defined E-box sequences, CACGTG, CATGCG, and CACGCG were well clustered near the TSS region. A bin size of 50, and a total of 18,193
promoter sequences spanning 3 kb upstream and 1 kb downstream of the TSS were used in this analysis. (B) Number of promoters that contained
each E-box element in the region between 2800 bp, and +200 bp of the TSS. (C) The relationship between the presence of each E-box sequence in
the promoter region (between 2800 bp, and +200 bp of the TSS), and Myc binding represented by the log2 red/green ratio on the X axis. The Y-axis
represents the frequency of each E-box element. A moving window average (size 100) was applied to the frequency of the E-box sequence. The
canonical E-box sequence CACGTG, and the non-canonical E-box sequence CACGCG in promoters showed the strongest correlation with Myc
binding to its target promoters in HeLa cells.
doi:10.1371/journal.pone.0001798.g004
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between the presence of the canonical E-box sequence CACGTG
and Myc occupancy of a promoter. The E-box sequence
CACGCG showed lower correlation, while CACGAG,
CATGCG, CATGTG, and CAACGTG did not show any
significant correlation with Myc binding (Figure 4C). Another
postulated binding sequence, CACATG (the reverse complement
of CATGTG) also showed no enrichment in Myc target promoters
in our data (Supplementary Figure S2), although CACATG/
CATGTG have been previously shown to be enriched among
Myc binding sites [22]. However, the previous study also
examined intronic and intergenic sites which were not included
in our promoter arrays, and this could potentially reflect
differences in the occurrence of Myc motifs in different types of
target sites. Overall, our data show that Myc has a preference to
bind only some of the previously defined E-box sequences in vivo.
Interestingly although the E-box CATGCG is enriched at
proximal promoter regions (Figure 4A) it did not show a significant
correlation with Myc occupancy in vivo.
To obtain a more detailed understanding of in vivo Myc usage
of its binding sites, we examined the relationship between Myc
occupancy and the presence of each E-box sequence within the
subset of promoters that were most strongly or most weakly
occupied by Myc in vivo. More than half the promoters that were
most strongly occupied by Myc (the top 2%) contained the
CACGTG sequence (Figure 5A). The promoters most strongly
occupied by Myc showed a increased frequency of all the
previously defined E-box sequences except, interestingly,
CATGTG. We observed the same trend when we examined the
top or bottom 10% of promoters occupied by Myc (Figure 5B).
Our data thus suggest that Myc has a marked preference to utilize
promoters in vivo that contain any of the known E-box sequences
except CATGTG. However, E-box sequences CACGTG and
CACGCG showed the strongest correlations with Myc occupancy
(Figure 4C).
To determine whether the most strongly preferred Myc sites,
CACGTG and CACGCG, were both also used under distinct
physiological conditions that might affect Myc binding, we
separately analyzed ChIP-chip data from quiescent and serum-
stimulated foreskin fibroblasts. Promoters containing the highly
preferred CACGTG sequence were preferentially occupied by
Myc in both conditions in foreskin fibroblasts, but promoters with
the CACGCG sequence did not show significant correlation with
Myc binding (Figure 6A and B). We also did not observe a strong
correlation between any of the other E-box sequences and Myc
binding in serum-starved fibroblasts, or in serum-stimulated
fibroblasts. As a control, we examined the occupancy of E2F4 at
these same promoters in quiescent fibroblasts. Despite the fact that
there are several common targets for both Myc and E2F4, we did
not observe a significant correlation between the presence of the
E-box sequences and E2F4 binding, which implies that the E-box
sequence is specific to Myc, but not to E2F4 (Figure 6C).
Taken together, our data indicate that the oncoprotein Myc
strongly prefers to use promoters containing the E-box sequence
CACGTG in vivo, although most of the other E-box sequences
except CATGTG appeared to be utilized in vivo to varying
extents. The discrepancy between our observations and previous
findings might be due to the fact that most of the previous
experiments were performed in vitro, and also did not consider the
number of actual E-box sequences present in the promoter. We
observed an increase in Myc binding to promoters that contain
each of the previously defined E-box sequences, except CATGTG.
However, the contribution of most E-box sequences to Myc
binding in vivo is low except for the E-box sequence CACGTG.
Materials and Methods
Cell lines and antibody
Human HeLa cells and human fibroblasts derived from foreskin
(ATCC CRL 2091) were grown to about 60% confluency in
15 cm plates in DMEM containing glucose (1 g/liter), antibiotics,
Figure 5. The canonical E-box sequence CATGTG is not
preferred by Myc. The relationship between the presence of six E-
box sequences in the promoter (between 2800 bp and +200 bp of TSS)
and Myc binding was analyzed. (A) Top and bottom 2% Myc occupancy
data and (B) top and bottom 10% of Myc occupancy data were used.
Black bars in both panels represent target promoters that were
occupied by Myc and gray bars represent promoters that were not
occupied by Myc. Promoters that contained the E-box sequence
CATGTG did not show a positive correlation with Myc binding.
doi:10.1371/journal.pone.0001798.g005
Genome-Wide Myc Targets
PLoS ONE | www.plosone.org 8 2008 | Volume 3 | Issue 3 | e1798and 10% fetal bovine serum (FBS, Hyclone). Exponentially
growing HeLa cells were used for ChIP. For the serum starvation
experiment, fibroblasts were washed once with phosphate-
buffered saline (PBS) and twice with DMEM medium lacking
FBS. Low-serum DMEM medium (containing 0.1% FBS) was
added to the plates and incubated for 72 hours. For serum
activation, cells in low-serum medium were washed twice with
PBS, and DMEM medium containing 10% FBS was added to the
cells and incubated for 4 hours. For crosslinking, 37% formalde-
hyde was directly added to the media, and ChIP procedures were
subsequently performed using an anti-Myc antibody (sc-764x,
Santa Cruz).
Chromatin immunoprecipitation (ChIP)
HeLa cells and fibroblasts were cross-linked by the addition of
formaldehyde (1% final concentration) directly to tissue culture
plates and incubated for 7 min at room temperature. Cross-linking
was terminated by adding glycine to a final concentration of
125 mM. Cells were washed with cold PBS containing PMSF,
scraped off the plates, collected by centrifugation, and washed
again with PBS. After centrifugation, the pellet was resuspended in
SDS lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-Cl
pH 8.1, plus protease inhibitors) and incubated at room
temperature for 20 min. Cells were sonicated on ice, and
fragmented DNA was visualized on an agarose gel (average size
1 kb). The sample was centrifuged at 12000 rpm at 4uC for
10 min, and ChIP dilution buffer (1% Triton X-100, 2 mM
EDTA, 20 mM Tris-Cl pH 8.1, 150 mM NaCl, plus protease
inhibitors) was added to the collected supernatant. The sample was
precleared with protein A-agarose beads (previously washed with
ChIP dilution buffer) at 4uC for 1 hour. Precleared chromatin was
incubated with an antibody against Myc (sc-764x, Santa Cruz) at
4uC overnight. For the mock IP controls, the antibody was not
added. Prewashed protein A-agarose beads were added and
protein-DNA complexes were recovered after a 2 hour incubation
at 4uC. Immunoprecipitated complexes were successively washed
twice with low salt wash buffer (0.1% sodium deoxycholate, 1%
Triton X-100, 1 mM EDTA, 50 mM HEPES pH 7.5, 150 mM
NaCl), once with high-salt wash buffer (0.1% sodium deoxycho-
late, 1% Triton X-100, 1 mM EDTA, 50 mM HEPES pH 7.5,
500 mM NaCl), once with LiCl wash buffer (250 mM LiCl, 0.5%
NP-40, 0.5% sodium deoxycholate, 1 mM EDTA, 10 mM Tris-Cl
pH 8.1), and twice with TE buffer (10 mM Tris-Cl pH 7.5, 1 mM
EDTA). SDS elution buffer was added and incubated at 65uC for
30 min to recover protein-DNA complexes. Crosslinks were
reversed by incubating at 65 uC overnight. The sample was
treated with RNase A and Proteinase K, extracted with phenol/
chloroform, and precipitated. The pellet was resuspended in 25 ml
of water.
Ligation mediated PCR (LM-PCR)
LM-PCR was performed as described [26] with minor
modifications. LM-PCR consisted of three steps: blunting of ChIP
DNA, ligation of linkers to ChIP DNA, and PCR. Approximately
200 ng of immunoprecipitated DNA was diluted to a final volume
of 100 ml with water. A mixture of 11 ml 10X T4 DNA
polymerase buffer, 0.5 ml BSA (10 mg/ml), 0.5 ml dNTP mix
(25 mM each), and 0.2 ml T4 DNA polymerase (3 U/ml) was
added, mixed by pipetting, and incubated at 12uC for 20 min.
After the incubation, 11.5 ml 3M sodium acetate, and 0.5 ml
glycogen (20 mg/ml) were added. The sample was extracted with
120 ml of phenol/chloroform/isoamyl alcohol (25:24:1) in a 0.5 ml
Phase-Lock Gel tube (Eppendorf) and centrifuged for 5 min at
maximum speed in a microcentrifuge. The upper phase was
transferred to a new 1.5-ml Eppendorf tube and precipitated with
230 ml ice-cold ethanol (100%). After centrifugation, the pellet was
washed with 70% ethanol and air dried briefly. The pellet was
resuspended in 25 ml water and placed on ice. Ligase mix
containing 8 ml water, 10 ml 5X ligase buffer, 6.7 ml annealed
linkers, and 0.5 ml T4 DNA ligase was added and incubated
overnight at 16uC. Linkers were prepared as follows: 300 ml each
of oligo Long (40 mM stock, sequence: 59-GCGGTGACCCGG-
GAGATCTGAATTC), and oligo Short (40 mM stock, sequence:
59-GAATTCAGATC) were mixed. 50-ml aliquots of oligo mixture
were placed at 95uC for 5 min, 70uC for 5 min and placed at
room temperature for 20 min. Aliquots were then transferred to
Figure 6. E-box usage in foreskin fibroblasts. The relationship between the presence of the two E-box sequences (CACGTG, and CACGCG) and
Myc binding represented by the log2 red/green ratio in (A) quiescent foreskin fibroblasts, and (B) in serum stimulated fibroblasts is shown. Only the
canonical E-box sequence CACGTG showed good correlation with Myc binding in both conditions. Average moving window (size 100) was applied to
the frequency of E-box sequence. (D) E2F4 ChIP-chip data was used as a negative control, and showed no correlation with E-box elements.
doi:10.1371/journal.pone.0001798.g006
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stored at 220uC.
To precipitate the linker-ligated DNA, 6 ml of 3 M sodium
acetate (pH 5.2) and 130 ml of cold ethanol were added to the tube
and centrifuged for 15 min at 4uC. The pellet was washed with
70% ethanol and resuspended in 25 ml water. A mixture of 4 ml
10X PCR buffer, 6.75 ml water, 2 ml low TTP mix (5 mM each
dATP, dCTP, dGTP, and 2 mM dTTP), 1 ml Cy3-dUTP or Cy5-
dUTP, and 1.25 ml of oligo Long (40 mM), was added to the
sample DNA and transferred to PCR tubes. PCR was performed
as follows: first, 2 min at 55uC, followed by addition of a mixture
of 8 ml water,1 ml 10X PCR buffer, and 1 ml Taq polymerase
(5 U/ml ), 5 min at 72uC, 2 min at 95uC, 35 cycles of 30 sec at
95uC, 30 sec at 55uC, and 1 min at 72uC. After PCR
amplification, 5 ml of sample was loaded on a 1.5% agarose gel
to verify the size of amplified ChIP DNA. The average size of
amplified ChIP DNA was approximately 400 bp. The remaining
PCR product was purified using a Qiaquick PCR purification kit
(Qiagen), and eluted in 13 ml of water.
Microarrays and data analysis
Human core promoter microarrays were manufactured as
described [44]. Amplified and fluorescently labeled ChIP and
reference DNA samples were simultaneously hybridized to the
microarrays and ChIP enrichment of target loci was calculated
based on significant ratios of ChIP signal to reference signal at each
spot. Independent biological replicate experiments were combined
by averaging the red/green ratio of each spot on microarrays. The
confidence of the ratio measurement was calculated as a p-value
using a previously described error model [25,26,45]. Microarray
elements whose red/green ratio was $2a n dp-value was #0.005
were considered to be direct targets of Myc.
Supporting Information
Figure S1 Gene expression changes for the subset of genes
whose promoters were occupied by Myc in serum starved
fibroblasts (designated ‘‘2091’’) but not in serum stimulated
fibroblasts. Expression data is taken from Gu & Iyer (2006)
Genome Biol 7: R42, and is shown for the genes in this category
for which data was available in the previous dataset.
Found at: doi:10.1371/journal.pone.0001798.s001 (0.52 MB TIF)
Figure S2 Occurrence of the CACATG motif among target
promoters, compared to the canonical CACGTG and CACGCG
motifs. No enrichment is evident.
Found at: doi:10.1371/journal.pone.0001798.s002 (0.62 MB TIF)
Table S1 List of 1469 Myc direct target genes identified in this
work, and overlap with previously identified targets from global
ChIP studies. The occurrence of the consensus motif CACGTG
among target promoters is also indicated.
Found at: doi:10.1371/journal.pone.0001798.s003 (0.19 MB
XLS)
Table S2 Functional categories of Myc target genes identified in
this study.
Found at: doi:10.1371/journal.pone.0001798.s004 (0.37 MB
XLS)
Table S3 Nuclear encoded genes involved in mitochondrial
biogenesis whose promoters were occupied by Myc.
Found at: doi:10.1371/journal.pone.0001798.s005 (0.03 MB
XLS)
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